OKUR
OnKure Therapeutics, Inc.Company with tickers: OKUR
CIK
1637715
CUSIP
68277Q105
Shares Outstanding
40,395,480
Website
https://www.onkure.com
13F Activity (30d)
24 filings
24 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Edward T. Mathers | Class II director | Appointed | 2026-06-04 |
| Valerie M. Jansen, M.D., Ph.D. | Class II director | Appointed | 2026-06-04 |
| R. Michael Carruthers | Class II director | Appointed | 2026-06-04 |